Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Post-marketing reevaluation of urinary kallidinogenase in acute anterior circulation cerebral infarction
ChiCTR-IPC-15007039Phase 4Recruiting
- Sponsor
- Peking Union Medical College Hospital
- Start
- Jun 2015
- Modality
- Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of Human urinary kallidinogenase in brain infarction and ischemic stroke, sponsored by Peking Union Medical College Hospital. Primary endpoint: Safety. Started Jun 2015; status: recruiting.
02
Drugs
Human urinary kallidinogenase
03
Conditions
brain infarctionischemic stroke
Beyond the preview
Go deeper on ChiCTR-IPC-15007039.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPC-15007039.